🇺🇸 FDA
Patent

US 7781445

Synthesis of indenoisoquinoliniums and methods of use

granted A61PA61P35/00

Quick answer

US patent 7781445 (Synthesis of indenoisoquinoliniums and methods of use) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Aug 19 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Aug 24 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 19 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61P, A61P35/00